Biochemical and pharmacological characteristics of a newly synthesized H+/K+-ATPase inhibitor, YJA20379-8, 3-butyryl-4-[R-1-methylbenzyl amino]-8-ethoxy-1,7-naphthyridine, in pigs and rats

Journal of Pharmacy and Pharmacology

Volumn 51, Issue 12, 1999, Pages 1359-1365

  Sohn, Sang Kwon ^a   Chang, Man Sik ^a   Choi, Wahn Soo ^a   Chung, Young Kuk ^a   Kim, Kyu Bong ^a   Woo, Tae Wook ^a   Lee, Seok Bong ^a   Park, Chong Jeun ^b  

^a Yungjin Pharm Co Ltd   (South Korea)

^b Sungkyunkwan University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

3 BUTYRYL 4 (5 METHYLBENZYLAMINO) 8 ETHOXY 1,7 NAPHTHYRIDINE; ANTIULCER AGENT; HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE; OMEPRAZOLE; PROTON PUMP INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; IC 50; MALE; MICROSOME; NONHUMAN; PH; RAT; STOMACH ACID SECRETION; STOMACH LESION; STRESS; WATER IMMERSION;

EID: 0033394085     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357991777173     Document Type: Article

References (21)

1. Berglindh, T., Dibona, D. R., Ito, S., Sachs, G. (1980) Probes of parietal cell function. Am. J. Physiol. 238: G165-G176
2. Chung, S. Y., Han, K. S., Chung, Y. K., Chang, M. S., Lee, M. G. (1998) Stability, blood, partition, and pharmacokinetics of a new proton pump inhibitor, YJA20379-8. Res. Commun. Mol. Pathol. Pharmacol. 100: 187-200
3. Chung, S. Y., Han, K. S., Kim, H. J., Kim, J. H., Chang, M. S., Lee, M. G. (1999) Gastrointestinal absorption of a new reversible proton pump inhibitor, YJA20379-8, in rats and its pharmacokinetics after oral administration to rats with acetic acid-induced gastric ulcer. J. Pharm. Pharmacol. 51: 1025-1030
4. Classen, M., Dammann, H. G., Domschke, W., Hüttemann, W., Londong, W., Rehner, M., Simon, B., Witzel, L., Berger, J. (1985) Omeprazole heals duodenal, but not gastric ulcers more rapidly than ranitidine. Results of two German multicentre trials. Hepatogastroenterology 32: 243-245
5. Fiske, C. H., Subbarow, Y. (1925) The colorimetric determination of phosphorus. J. Biol. Chem. 66: 375-400
6. Forte, J. G., Lee, H. C. (1977) Gastric adenosine triphosphatases: a review of their possible role in HCl secretion. Gastroenterology 73: 921-926
7. Hersey, S. J., Sachs, G. (1995) Gastric acid secretion. Physiol. Rev. 75: 155-189
8. +-ATPase in-vivo by omeprazole. Biochem. Biophys. Res. Commun. 126: 78-82
9. Kim, J. H., Kim, E. J., Han, K. S., Chang, M. S., Lee, M. G. (1999) Gastrointestinal first-pass effect of YJA20379-8, a new reversible proton pump inhibitor, in rats. J. Pharm. Pharmacol. In press
10. Kitagawa, H., Fujiwara, M., Osumi, Y. (1979) Effects of water-immersion stress on gastric secretion and mucosal blood flow in rats. Gastroenterology 77: 298-302
11. Lindberg, P., Nordberg, P., Alminger, T., Brändström, A., Wallmark, B. (1986) The mechanism of action of the gastric acid-secretion inhibitor omeprazole. J. Med. Chem. 29: 1327-1329
12. Long, J. F., Chiu, P. J. S., Derelanko, M. J., Steinberg, M. (1983) Gastric antisecretory and cytoprotective activities of SCH28080. J. Pharmacol. Exp. Ther. 226: 114-120
13. Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275
14. +-ATPase, SK&F 97574. II. pharmacological properties. Biochem. Pharmacol. 50: 1551-1556
15. +-ATPase, SK&F 97574. I. In-vitro activity. Biochem. Pharmacol. 50: 1543-1549
16. +-ATPase containing vesicles by zonal centrifugation and free flow electrophoresis technique. Biochim. Biophys. Acta. 465: 311-330
17. +-ATPase as therapeutic target. Annu. Rev. Pharmacol. Toxicol. 28: 269-284
18. Shay, M., Sun, O. C. H., Gruenstein, M. (1954) A quantitative method for measuring spontaneous gastric secretion in the rat. Gastroenterology 26: 906-913
19. Tytgat, G. N. J., Lamers, C. B. H. W., Wilson, J. A., Hameeteman, W., Jansen, J. B. M. J., Wormsley, K. G. (1985) 100% healing with omeprazole of peptic ulcers resistant to histamine H2-receplor antagonists. Gastroenterology 88: 1620
20. +-ATPase within the parietal cell. Biochim. Biophys. Acta. 778: 549-558
21. +-ATPase inhibitors. J. Med. Chem. 39: 596-604